Patents Assigned to Roxane Laboratories, Inc.
  • Formulation and manufacturing process for calcium acetate capsules
    Patent number: 9060951
    Abstract: The present invention relates to a pharmaceutical calcium acetate formulation and a process for making the same. In particular, the present invention relates to a calcium acetate capsule formulation comprising granules comprising calcium acetate along with other formulation adjuvants contained within a pharmaceutically acceptable capsule.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: June 23, 2015
    Assignee: Roxane Laboratories, Inc.
    Inventors: Julie Economou, Shehla Uraizee
  • FORMULATION AND MANUFACTURING PROCESS FOR CALCIUM ACETATE CAPSULES
    Publication number: 20140010869
    Abstract: The present invention relates to a pharmaceutical calcium acetate formulation and a process for making the same. In particular, the present invention relates to a calcium acetate capsule formulation comprising granules comprising calcium acetate along with other formulation adjuvants contained within a pharmaceutically acceptable capsule.
    Type: Application
    Filed: September 16, 2013
    Publication date: January 9, 2014
    Applicant: Roxane Laboratories, Inc.
    Inventors: Julie Economou, Shehla Uraizee
  • Formulation and manufacturing process for calcium acetate capsules
    Patent number: 8563032
    Abstract: The present invention relates to a pharmaceutical calcium acetate formulation and a process for making the same. In particular, the present invention relates to a calcium acetate capsule formulation comprising granules comprising calcium acetate along with other formulation adjuvants contained within a pharmaceutically acceptable capsule.
    Type: Grant
    Filed: December 5, 2006
    Date of Patent: October 22, 2013
    Assignee: Roxane Laboratories, Inc.
    Inventors: Julie Economou, Shehla Uraizee
  • Pharmaceutical formulation and process comprising a solid dispersion of macrolide (tacrolimus)
    Patent number: 8501764
    Abstract: The present invention relates to a pharmaceutical formulation and process for preparing the same comprising an oral dosage formulation, such as a capsule formulation, of a macrolide compound, such as tacrolimus, wherein the capsule formulation contains both a solid dispersion of the macrolide along with a non-dispersed form of the macrolide. The pharmaceutical formulation according to the invention is bioequivalent to the FDA approved product according to a bioavailability study conducted in humans.
    Type: Grant
    Filed: June 13, 2012
    Date of Patent: August 6, 2013
    Assignee: Roxane Laboratories, Inc.
    Inventors: Greg A. Brubaker, Thomas D. Mahon
  • Pharmaceutical formulation and process comprising a solid dispersion of macrolide (tacrolimus)
    Patent number: 8222272
    Abstract: The present invention relates to a pharmaceutical formulation and process for preparing the same comprising an oral dosage formulation, such as a capsule formulation, of a macrolide compound, such as tacrolimus, wherein the capsule formulation contains both a solid dispersion of the macrolide along with a non-dispersed form of the macrolide. The pharmaceutical formulation according to the invention is bioequivalent to the FDA approved product according to a bioavailability study conducted in humans.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: July 17, 2012
    Assignee: Roxane Laboratories, Inc.
    Inventors: Greg A. Brubaker, Thomas D. Mahon
  • Galantamine tablet formulation
    Publication number: 20080145422
    Abstract: The present invention relates to a direct compression tablet formulation comprising, as the active ingredient, galantamine, and more specifically, galantamine hydrobromide along with a process of making the same. The tablet formulation is a direct compression tablet and has excellent content uniformity and dissolution properties.
    Type: Application
    Filed: February 10, 2005
    Publication date: June 19, 2008
    Applicant: Roxane Laboratories, Inc.
    Inventors: Yunlong Zhou, Andrea McPhillips, Julie Economou
  • Opioid Sustained Release Formulation
    Publication number: 20060263431
    Abstract: A solid, oral, controlled release dosage form comprising a therapeutically effective amount of an opioid compound, or a salt thereof, a matrix-forming polymer and an ionic exchange resin.
    Type: Application
    Filed: August 3, 2006
    Publication date: November 23, 2006
    Applicant: Roxane Laboratories, Inc.
    Inventor: Ann Maloney
  • Abuse-resistant sustained-release opioid formulation
    Publication number: 20050163856
    Abstract: A method for reducing the abuse potential of an oral dosage form of an opioid extractable by commonly available household solvents said method comprising combining a therapeutically effective amount of the opioid compound, or a salt thereof, a matrix-forming polymer and an ionic exchange resin.
    Type: Application
    Filed: March 23, 2005
    Publication date: July 28, 2005
    Applicant: Roxane Laboratories, Inc.
    Inventors: Ann Maloney, Debra Murwin, Michael Schobelock
  • Opioid sustained release formulation
    Publication number: 20040062812
    Abstract: A solid, oral, controlled release dosage form comprising a therapeutically effective amount of an opioid compound, or a salt thereof, a matrix-forming polymer and an ionic exchange resin.
    Type: Application
    Filed: September 5, 2003
    Publication date: April 1, 2004
    Applicant: Roxane Laboratories, Inc.
    Inventor: Ann M. Maloney
  • Abuse-resistant sustained-release opioid formulation
    Publication number: 20030118641
    Abstract: A method for reducing the abuse potential of an oral dosage form of an opioid extractable by commonly available household solvents said method comprising combining a therapeutically effective amount of the opioid compound, or a salt thereof, a matrix-forming polymer and an ionic exchange resin.
    Type: Application
    Filed: October 3, 2002
    Publication date: June 26, 2003
    Applicant: Roxane Laboratories, Inc.
    Inventors: Ann Maloney, Debra Marie Murwin, Michael Jay Schobelock